Aerie Pharmaceuticals (AERI)
15.25 +0.01 (+0.07%) 11/19/22 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2022 | 06-2022 | 03-2022 | 12-2021 | 09-2021 | |
| Sales | 36,129 | 33,311 | 29,835 | 114,666 | 29,313 |
| Cost of Goods | 6,929 | 3,741 | 6,780 | 6,070 | 7,899 |
| Gross Profit | 29,200 | 29,570 | 23,055 | 108,596 | 21,414 |
| Operating Expenses | 56,801 | 48,448 | 57,478 | 56,926 | 54,687 |
| Operating Income | -26,672 | -18,137 | -33,643 | 51,740 | -32,374 |
| Other Income | -59 | -1,186 | -1,555 | -5,721 | -7,259 |
| Pre-tax Income | -26,731 | -19,323 | -35,198 | 46,019 | -39,633 |
| Income Tax | 95 | 48 | 693 | 486 | 58 |
| Net Income Continuous | -26,826 | -19,371 | -35,891 | 45,533 | -39,691 |
| Net Income | $-26,826 | $-19,371 | $-35,891 | $45,533 | $-39,691 |
| EPS Basic Total Ops | -0.56 | -0.41 | -0.76 | 1.00 | -0.86 |
| EPS Basic Continuous Ops | -0.56 | -0.41 | -0.76 | 0.99 | -0.86 |
| EPS Diluted Total Ops | -0.56 | -0.41 | -0.76 | 1.00 | -0.86 |
| EPS Diluted Continuous Ops | -0.56 | -0.41 | -0.76 | 0.99 | -0.86 |
| EPS Diluted Before Non-Recurring Items | -0.27 | -0.32 | -0.66 | 1.09 | -0.72 |
| EBITDA(a) | $-23,324 | $-14,712 | $-30,032 | $61,523 | $-22,766 |